Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

BACKGROUND AND AIMS: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer; few treatments exist for patients with advanced disease. Once tumors metastasize to distant sites, patients generally receive chemotherapy, but response duration and progression-free survival (PFS) are typically shor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Becker, Jürgen C., Lorenz, Eva, Ugurel, Selma, Eigentler, Thomas K., Kiecker, Felix, Pföhler, Claudia, Kellner, Ivonne, Meier, Friedegund, Kähler, Katharina, Mohr, Peter, Berking, Carola, Haas, Gabriele, Helwig, Christoph, Oksen, Dina, Schadendorf, Dirk, Mahnke, Lisa, Bharmal, Murtuza
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668086/
https://ncbi.nlm.nih.gov/pubmed/29108353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados